Messenger RNA transformed vaccine science during the COVID-19 pandemic, but its success depended on a delivery system capable of protecting a fragile genetic molecule and transporting it into cells. Researchers at Nagoya University and FUJIFILM Corporation have now reported a lipid nanoparticle platform designed to carry both conventional linear mRNA and a more durable form of circular RNA. In experiments in mice, the system delivered genetic in…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.